In another study, Benedicto et al. reported that disruption of CXCR4/CXCL12 axis by CXCR4 antagonist AMD3100 inhibited the contribution of cancer and stromal cells to the metastatic cascade in the liver (109). The gene discussed is CXCL12; the disease is cancer.